These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31952864)

  • 21. The Associations of Prescription Drug Insurance and Cost-Sharing With Drug Use, Health Services Use, and Health: A Systematic Review of Canadian Studies.
    Guindon GE; Stone E; Trivedi R; Garasia S; Khoee K; Olaizola A
    Value Health; 2023 Jul; 26(7):1107-1129. PubMed ID: 36842717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variability in prescription medication coverage for children and youth across Canada: A scoping review.
    Ahmad A; Abbas M; Miregwa B; Holbrook AM
    Health Policy; 2022 Mar; 126(3):269-279. PubMed ID: 35140016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significant disparities in eyeglass insurance coverage in Canada.
    Ngo G; Trope G; Buys Y; Jin YP
    Can J Ophthalmol; 2018 Jun; 53(3):260-265. PubMed ID: 29784163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prescription drug benefits and Canada's uninsured.
    Dewa CS; Hoch JS; Steele L
    Int J Law Psychiatry; 2005; 28(5):496-513. PubMed ID: 16125777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug insurance instability and its correlates: results from the 2000 Medical Expenditure Panel Survey.
    Gupta K; Cline RR; Schondelmeyer SW
    Res Social Adm Pharm; 2006 Jun; 2(2):232-53. PubMed ID: 17138510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Socio-demographic predictors of not having private dental insurance coverage: machine-learning algorithms may help identify the disadvantaged.
    Duvvuri VR; Abdelrehim M; Singhal S
    BMC Public Health; 2024 May; 24(1):1386. PubMed ID: 38783219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the Affordable Care Act's young adult insurance expansion on prescription drug insurance coverage, utilization, and expenditures.
    Look KA; Arora P
    Res Social Adm Pharm; 2016; 12(5):682-98. PubMed ID: 26632980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare".
    Rawson NSB
    Int J Health Policy Manag; 2020 Dec; 9(12):524-527. PubMed ID: 32610769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of cost on adherence to prescription medications in Canada.
    Law MR; Cheng L; Dhalla IA; Heard D; Morgan SG
    CMAJ; 2012 Feb; 184(3):297-302. PubMed ID: 22249979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Socioeconomic status, access to health care, and outcomes after acute myocardial infarction in Canada's universal health care system.
    Pilote L; Tu JV; Humphries K; Behouli H; Belisle P; Austin PC; Joseph L
    Med Care; 2007 Jul; 45(7):638-46. PubMed ID: 17571012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. It Won't Be Easy: How to Make Universal Pharmacare Work in Canada.
    Lewis S
    Int J Health Policy Manag; 2020 Jan; 9(1):1-5. PubMed ID: 31902189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Six Myths About Pharmacare.
    Lexchin J
    Health Law Can; 2017 Feb; 37(2-3):44-51. PubMed ID: 30005520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescription drug insurance and unmet need for health care: a cross-sectional analysis.
    Hanley GE
    Open Med; 2009; 3(3):e178-83. PubMed ID: 21603050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of prescription drug insurance on psychotropic and non-psychotropic drug utilization in Canada.
    Sarma S; Basu K; Gupta A
    Soc Sci Med; 2007 Dec; 65(12):2553-65. PubMed ID: 17761377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study on cost-related medication nonadherence in Ontario.
    Zheng B; Poulose A; Fulford M; Holbrook A
    J Popul Ther Clin Pharmacol; 2012; 19(2):e239-47. PubMed ID: 22805096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease.
    Federman AD; Adams AS; Ross-Degnan D; Soumerai SB; Ayanian JZ
    JAMA; 2001 Oct; 286(14):1732-9. PubMed ID: 11594898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Socioeconomic status, service patterns, and perceptions of care among survivors of acute myocardial infarction in Canada.
    Alter DA; Iron K; Austin PC; Naylor CD;
    JAMA; 2004 Mar; 291(9):1100-7. PubMed ID: 14996779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs.
    Buttorff C; Andersen MS; Riggs KR; Alexander GC
    Health Aff (Millwood); 2015 Mar; 34(3):467-76. PubMed ID: 25732498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inequity in publicly funded physician care: what is the role of private prescription drug insurance?
    Allin S; Hurley J
    Health Econ; 2009 Oct; 18(10):1218-32. PubMed ID: 19097042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of supplemental coverage in a universal health insurance system: Some Canadian evidence.
    Devlin RA; Sarma S; Zhang Q
    Health Policy; 2011 Apr; 100(1):81-90. PubMed ID: 20810187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.